Algo version: 0.98b
Neuland Laboratories is listed at the NSE Exchange
Neuland Laboratories [NEULANDLAB.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Neuland Laboratories stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Neuland Laboratories pays dividends. Last time was Friday 30th of August 2024 where the investors holding the stock on Friday 12th of July 2024 were paid INR14 per share. Over the last 12 times between 2009 and 2024, Neuland Laboratories has paid INR46.9 with an average of INR3.91 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Neuland Laboratories 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR494.80, you would have made a profit of INR12 410 per share or 2 508.09%

Yes, the average daily trading liquidity for Neuland Laboratories is INR46 894 thousand. You should therefore be able to get in and out of your positions relatively fast.

Neuland Laboratories has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.00, the company's ability to pay off the debt is good. Neuland Laboratories has a good net profit margin of 19.25% and should have high tolerances against inflation.

We have calculated the inflation risk for Neuland Laboratories to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.